Hikma Pharmaceuticals (HIKL)

1,858.00p
   
  • Change Today:
      0.22p
  • 52 Week High: 2,348.00p
  • 52 Week Low: 1,595.50p
  • Currency: UK Pounds
  • Shares Issued: 199.39m
  • Volume: 139,633
  • Market Cap: £3,704.58m

HIKL Overview

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma’s operations are in the United States, the Middle East and North Africa Region and Europe.

Key Personnel

CEO: Riad Mishlawi
Executive Chairman: Said Darwazah
Executive Vice Chairman: Mazen Darwazah
Independent Non-Executive Director: Douglas Hurt
Independent Non-Executive Director: Laura Balan Balan
Independent Non-Executive Director: Mary (Nina) Henderson
Independent Non-Executive Director: Cynthia Schwalm
Independent Non-Executive Director: Deneen Vojta
Senior Independent Director: Victoria Hull
Non-Executive Dir: Ali Al-Husry

Contact Details

Address: 1 New Burlington Place, London,United Kingdom, W1S 2HR
Phone: +44 (0)20 7399 2760
Fax: +44 (0)20 7399 2761
Website: http://www.hikma.com

Listings

Overseas Listings: LSE:HIK
ISIN: GB00B0LCW083

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 5 minutes.

 

HIKL Market Data

Currency UK Pounds
Share Price 1,858.00p
Change Today 0.22p
% Change 1.20 %
52 Week High 2,348.00p
52 Week Low 1,595.50p
Volume 139,633
Shares Issued 199.39m
Market Cap £3,704.58m

Trades for 09-Oct-2025

Time Volume / Share Price
16:29 473 @ 1,857.00p
16:29 74 @ 1,857.00p
16:29 33 @ 1,857.00p
16:29 29 @ 1,857.00p
16:29 213 @ 1,857.00p

HIKL Key Personnel

CEO Riad Mishlawi

Top of Page